Free Review Articles on Implanted cardioverter defibrillator                                 Metatextbook

Freie Reviews über Implantierbarer Kardioverter Defibrillator                                 Look here for Journal Homepages

  • Implanted cardioverter defibrillator
  • Premedication and perioperative medicine
  • Azimilide
  • Cardiac pacemaker (biventricular)
  • Cardiac pacemaker (BASKET)
  • Heart (Extrasystole ventricular and salve)
  • Sudden death (cardiogenic)
  • Cardiovascular risk
  • Long QT syndrome
  • Short QT syndrome
  • Heart (Inherited and congenital diseases in grown up patients)
  • Kidney (Chronic renal failure)
  • Electrical storm
  • Amiodarone
  • Heart (Ventricular fibrillation)
  • Resuscitation
    • Nr.Year

    OPEN

    		Titleusers

    say

    		rate

    good

    		rate

    bad

    no link

    		Citation
    12003Implantable devices for treating tachyarrhythmias.



    		+-nlBMJ 327(7410):333-6 (2003)
    22009Expenditure and value for money: the challenge of implantable cardioverter defibrillators.



    		+-nlQJM 102(5):349-56 (2009)
    32003Implantable defibrillator therapy.



    		+-nlNeth J Med 61(5 Suppl):4-7 (2003)
    42005Practice advisory for the perioperative management of patients with cardiac rhythm management devices: pacemakers and implantable cardioverter-defibrillators: a report by the American Society of Anesthesiologists Task Force on Perioperative Management of Patients with Cardiac Rhythm Management Devices.



    		+-nlAnesthesiology 103(1):186-98 (2005)
    52007Primary and secondary prevention of sudden cardiac death: who should get an ICD?



    		+-nlHeart 93(11):1478-83 (2007)
    62002Implantable cardioverter-defibrillators in arrhythmias: a rapid and systematic review of effectiveness.



    		+-nlHeart 87(5):438-42 (2002)
    72001Implantable cardioverter-defibrillators.



    		+-nlHeart 86(2):221-6 (2001)
    82009Inappropriate implantable cardioverter-defibrillator therapy: many causes and many possible solutions.



    		+-nlCardiol J 16(5):391-3 (2009)
    92004Arrhythmia detection by dual-chamber implantable cardioverter defibrillators. A review of current algorithms.



    		+-nlEuropace 6(4):273-86 (2004)
    102009A randomized study to compare ramp versus burst antitachycardia pacing therapies to treat fast ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators: the PITAGORA ICD trial.



    		+-nlCirc Arrhythm Electrophysiol 2(2):146-53 (2009)
    112008Should patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% undergo prophylactic implantation of an ICD? Implantable cardioverter defibrillator implantation guidelines based solely on left ventricular ejection fraction do not apply to adults with congenital heart disease.



    		+-nlCirc Arrhythm Electrophysiol 1(4):307-16; discussion 316 (2008) Triedman JK
    122008Should patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% undergo prophylactic implantation of an ICD? Patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% should undergo prophylactic implantation of an implantable cardioverter defibrillator.



    		+-nlCirc Arrhythm Electrophysiol 1(4):298-306 (2008)
    132006A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.



    		+-nlHealth Technol Assess 10(27):iii-iv, ix-xi, 1-164 (2006)
    142005The clinical and cost-effectiveness of implantable cardioverter defibrillators: a systematic review.



    		+-nlHealth Technol Assess 9(36):1-150, iii (2005)
    152000Implantable cardioverter defibrillators: arrhythmias. A rapid and systematic review.



    		+-nlHealth Technol Assess 4(26):1-69 (2000)
    162007Systematic review: implantable cardioverter defibrillators for adults with left ventricular systolic dysfunction.



    		+-nlAnn Intern Med 147(4):251-62 (2007)
    172003Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials.



    		+-nlAnn Intern Med 138(6):445-52 (2003)
    182000The role of the implantable cardioverter-defibrillator for prevention of sudden cardiac death.



    		+-nlAnn Intern Med 133(11):901-10 (2000)
    191995Implantable cardioverter-defibrillators: implications for the nonelectrophysiologist.



    		+-nlAnn Intern Med 122(10):770-7 (1995)
    202008Results of the Predictors of Response to CRT (PROSPECT) trial.



    		+-nlCirculation 117(20):2608-16 (2008)
    212007Highlighting the R in CRT.



    		+-nlCirculation 116(13):1434-6 (2007) Kass DA
    222007Sudden death prevention with implantable devices.



    		+-nlCirculation 116(5):561-71 (2007)
    232006ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.



    		+-nlCirculation 114(10):e385-484 (2006)
    242005Heart failure devices: implantable cardioverter-defibrillators and biventricular pacing therapy.



    		+-nlCirculation 111(24):3327-35 (2005)
    252005Should everyone with an ejection fraction less than or equal to 30% receive an implantable cardioverter-defibrillator? Everyone with an ejection fraction < or = 30% should receive an implantable cardioverter-defibrillator.



    		+-nlCirculation 111(19):2537-49; discussion 2537-49 (2005) Moss AJ
    262005Should everyone with an ejection fraction less than or equal to 30% receive an implantable cardioverter-defibrillator? Not everyone with an ejection fraction < or = 30% should receive an implantable cardioverter-defibrillator.



    		+-nlCirculation 111(19):2537-49; discussion 2537-49 (2005)
    272003MADIT II (second Multicenter Automated Defibrillator Implantation Trial) debate: risk stratification, costs, and public policy.



    		+-nlCirculation 108(15):1779-83 (2003)
    282002ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines).



    		+-nlCirculation 106(16):2145-61 (2002)
    291995The proarrhythmic potential of implantable cardioverter-defibrillators.



    		+-nlCirculation 92(6):1651-64 (1995)
    301995Clinical investigation of antiarrhythmic devices. A statement for healthcare professionals from a joint task force of the American Heart Association, the North American Society of Pacing and Electrophysiology, the American College of Cardiology, and the Working Groups on Arrhythmias and Cardiac Pacing of the European Society of Cardiology.



    		+-nlCirculation 91(7):2097-109 (1995)
    312007Adjunctive antiarrhythmic drug therapy in patients with implantable cardioverter defibrillators: a systematic review.



    		+-nlEur Heart J 28(4):469-77 (2007)
    322006ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.



    		+-nlEur Heart J 27(17):2099-140 (2006)
    332003MADIT-II and its implications.



    		+-nlEur Heart J 24(1):16-8 (2003)
    342001Indications for implantable cardioverter defibrillator (ICD) therapy. Study Group on Guidelines on ICDs of the Working Group on Arrhythmias and the Working Group on Cardiac Pacing of the European Society of Cardiology.



    		+-nlEur Heart J 22(13):1074-81 (2001)
    352000Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.



    		+-nlEur Heart J 21(24):2071-8 (2000)
    361997Defibrillators are superior to antiarrhythmic drugs in the treatment of ventricular tachyarrhythmias.



    		+-nlEur Heart J 18(1):26-30 (1997)
    372006Primary prevention of sudden cardiac death.



    		+-nlHeart 92(12):1873-8 (2006)
    382004The MADIT II and COMPANION studies: will they affect uptake of device treatment?



    		+-nlHeart 90(3):243-5 (2004)
    392004Implantable cardioverter-defibrillator treatment and resynchronisation in heart failure.



    		+-nlHeart 90(2):231-4 (2004)
    402003An audit of the implications of implementing NICE guidance on the use of implantable cardioverter-defibrillators.



    		+-nlHeart 89(7):787-8 (2003)
    412004Indications for an implantable cardioverter defibrillator (ICD).



    		+-nlIntern Med 43(5):360-7 (2004)
    422008American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death. A scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention.



    		+-nlJ Am Coll Cardiol 52(14):1179-99 (2008)
    432008Benefits of the implantable cardioverter-defibrillator.



    		+-nlJ Am Coll Cardiol 52(14):1122-7 (2008) Epstein AE
    442008A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death.



    		+-nlJ Am Coll Cardiol 52(14):1111-21 (2008)
    452008Azimilide: another effort to prevent implantable cardioverter-defibrillator shocks and their sequelae why it is important and how it works.



    		+-nlJ Am Coll Cardiol 52(13):1084-5 (2008) Cannom DS
    462008ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons.



    		+-nlJ Am Coll Cardiol 51(21):e1-62 (2008)
    472008Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction.



    		+-nlJ Am Coll Cardiol 51(3):288-96 (2008)
    482006Evaluation and management of patients after implantable cardioverter-defibrillator shock.



    		+-nlJAMA 296(23):2839-47 (2006)
    492004Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials.



    		+-nlJAMA 292(23):2874-9 (2004)
    502006Role of resynchronisation therapy and implantable cardioverter defibrillators in heart failure.



    		+-nlPostgrad Med J 82(963):16-23 (2006)
    512009Therapy with an implantable cardioverter defibrillator (ICD) in patients with coronary artery disease and dilated cardiomyopathy: benefits and disadvantages.



    		+-nlSwiss Med Wkly 139(45-46):647-53 (2009)
    522006ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death).



    		+-nlJ Am Coll Cardiol 48(5):e247-346 (2006)
    532006Implantable cardioverter-defibrillator therapy in clinical practice.



    		+-nlJ Am Coll Cardiol 47(8):1507-17 (2006)
    542004Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction: a pooled analysis of 10 primary prevention trials.



    		+-nlJ Am Coll Cardiol 44(11):2166-72 (2004)
    552004Filling the need for new antiarrhythmic drugs to prevent shocks from implantable cardioverter defibrillators.



    		+-nlJ Am Coll Cardiol 43(1):44-6 (2004) Curtis AB
    562003Effectiveness of implantable defibrillators for preventing arrhythmic events and death: a meta-analysis.



    		+-nlJ Am Coll Cardiol 41(9):1573-82 (2003)
    572008Fish-oil supplementation in patients with implantable cardioverter defibrillators: a meta-analysis.



    		+-nlCMAJ 178(2):157-64 (2008)
    582007Implantable cardioverter defibrillators work--so why aren't we using them?



    		+-nlCMAJ 177(1):49-51 (2007) Simpson CS
    592010Device sensing: sensors and algorithms for pacemakers and implantable cardioverter defibrillators.



    		+-nlCirculation 122(13):1328-40 (2010)
    602007Patients with hemodynamically tolerated ventricular tachycardia require implantable cardioverter defibrillators.



    		+-nlCirculation 116(10):1196-203 (2007)
    612007Transvenous implantable cardioverter-defibrillator leads: the weakest link.



    		+-nlCirculation 115(19):2461-3 (2007) Maisel WH
    622009Refining patient selection for primary prevention implantable cardioverter-defibrillator therapy: reeling in a net cast too widely.



    		+-nlCirculation 120(10):825-7 (2009)
    632008American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: a scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention.



    		+-nlCirculation 118(14):1497-1518 (2008)
    642009Treating the long-QT syndrome in the era of implantable defibrillators.



    		+-nlCirculation 119(2):204-6 (2009) Viskin S
    652004Potential candidates for cardiac resynchronization therapy in Japanese patients with idiopathic dilated cardiomyopathy--a Niigata multicenter study of DCM--.



    		+-nlCirc J 68(12):1104-9 (2004)
    662009Cardiac resynchronization therapy with and without implantable cardioverter-defibrillator.



    		+-nlCirc J 73 Suppl A(-):A29-35 (2009)
    672006Short QT syndrome and arrhythmogenic cardiac diseases in the young: the challenge of implantable cardioverter-defibrillator therapy for children.



    		+-nlEur Heart J 27(20):2382-4 (2006) Boriani G
    682007The cost of implantable defibrillators: perceptions and reality.



    		+-nlEur Heart J 28(4):392-7 (2007)
    692007The high cost of implantable defibrillators.



    		+-nlEur Heart J 28(4):388-91 (2007)
    702008What is the level of evidence for combined cardiac resynchronization and defibrillation therapy in heart failure?



    		+-nlEur Heart J 29(5):682-3; author reply 683-4 (2008)
    712010Subcutaneous ICD implantation.



    		+-nlRev Port Cardiol 29(3):451-7 (2010)
    722010Proportion of patients needing an implantable cardioverter defibrillator on the basis of current guidelines: impact on healthcare resources in Italy and the USA. Data from the ALPHA study registry.



    		+-nlEuropace 12(8):1105-11 (2010)
    732010Effectiveness of prophylactic implantation of cardioverter-defibrillators without cardiac resynchronization therapy in patients with ischaemic or non-ischaemic heart disease: a systematic review and meta-analysis.



    		+-nlEuropace 12(11):1564-70 (2010)
    742011Clinical practice of defibrillator implantation after myocardial infarction: impact of implant time: results from the PreSCD II registry.



    		+-nlEuropace 13(4):499-508 (2011)
    752010Role of antiarrhythmic drugs in patients with implantable cardioverter defibrillators.



    		+-nlEuropace 12(5):618-25 (2010)
    762008Tools and strategies for the reduction of inappropriate implantable cardioverter defibrillator shocks.



    		+-nlEuropace 10(11):1256-65 (2008)
    772009Implantable cardioverter defibrillators and their role in heart failure progression.



    		+-nlEuropace 11(6):710-5 (2009)
    782009Lifetime cost-effectiveness of prophylactic implantation of a cardioverter defibrillator in patients with reduced left ventricular systolic function: results of Markov modelling in a European population.



    		+-nlEuropace 11(6):716-26 (2009)
    792009Inappropriate shocks or inappropriate programming? A review of Guidant's reconfirmation algorithm.



    		+-nlEuropace 11(8):1120-2 (2009)
    802008Implantable cardioverter-defibrillator therapy in adult patients with tetralogy of Fallot.



    		+-nlEuropace 10(8):926-30 (2008)
    812009Cardiac resynchronization therapy in combination with implantable cardioverter-defibrillator.



    		+-nlEuropace 11 Suppl 5(-):v87-92 (2009)
    822009Implantable cardioverter defibrillator therapy in chronic kidney disease: a meta-analysis.



    		+-nlEuropace 11(11):1469-75 (2009)
    832009Implantable cardioverter defibrillator therapy for non-ischaemic cardiomyopathy. What is the role of programmed electrical stimulation?



    		+-nlEuropace 11(3):273-5 (2009) Plummer C
    842009Impact of the main implantable cardioverter-defibrillator trials in clinical practice: data from the Italian ICD Registry for the years 2005-07.



    		+-nlEuropace 11(4):465-75 (2009)
    852009Defibrillator implantation early after myocardial infarction.



    		+-nlN Engl J Med 361(15):1427-36 (2009)
    862011Current pacemaker and defibrillator therapy.



    		+-nlDtsch Arztebl Int 108(21):372-9; quiz 380 (2011)
    872008Electrical storm: a new challenge in the age of implantable defibrillators.



    		+-nlHellenic J Cardiol 49(2):86-91 (2008)
    882010Amiodarone for the treatment and prevention of ventricular fibrillation and ventricular tachycardia.



    		+-nlVasc Health Risk Manag 6(-):465-72 (2010)
    892002Implanted cardiac pacemakers and defibrillators in anaesthetic practice.



    		+-nlBr J Anaesth 88(5):627-31 (2002)
    902004Pacemakers and defibrillators: anaesthetic implications.



    		+-nlBr J Anaesth 93(1):95-104 (2004)



    Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

    All data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.